3Tefik T, Kucukgergin C, Sanli 0,et al. Manganese superoxidedismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463 Agene polymorphisms in patients with prostate cancer ; relation toadvanced and metastatic disease. BJU Int,2013 ,112(4) :406-414.
4Yamaguchi Y, Sato K, Endo H. Depression of catalase geneexpression in the liver of tumor bearing nude mice. Biochem BiophysRes Commun,1992 ,189(2) : 1084-1089.
5Wu SH, Lee KW, Chen CH, et al. Epistasis of oxidative stress-related enzyme genes on modulating the risks in oral cavity cancer.Clin Chim Acta, 2010,411(21-22) :1705-1710.
6Durak I, Perk H,Kavut? u M,et al. Adenosine deaminase, 5'nucleotidase,xanthine oxidase, superoxide dismutase,and catalaseactivities in cancerous and noncancerous human bladder tissues. FreeRadic Biol Med,1994,16(6) :825-831.
7GUner G, Islekel H,Oto O,et al. Evaluation of some antioxidantenzymes in lung carcinoma tissue. Cnncer Lett, 1996,103 ( 5 ):233-239.
8Yoo DG, Song YJ, Cho EJ,et al. Alteration of APEl/ref-1expression in non-small cell lung cancer: the implications of impairedextracellular superoxide dismutase and catalase antioxidant systems.Lung Cancer, 2008,60(2) :277-284.
9Tu H, Sun H, Lin Y, et al. Oxidative stress upregulates PDCD4expression in patients with gastric cancer via mir-21. Curr PharmDes,2014,20(11) :1917-1923.
10Kolanjiappan K, Ramachandran CR, Manoharan S. Biochemicalchanges in tumor tissues of oral cancer patients. Clin Biochem ,2003,?36) :61-65.
